162,329 research outputs found
[Report to Chief J. E. Curry, by an unknown author #1]
No full textReport to Chief J. E. Curry, by an unknown author. The report contains a list of officers who gave depositions to the United States Attorney
[Report to Chief J. E. Curry, by an unknown author #2]
No full textReport to Chief J. E. Curry, by an unknown author. The report contains a list of officers who gave depositions to the United States Attorney
Lymphomatous infilration of the peripheral nervous system in enteropathy-associated T-cell lymphoma
No full textThe document attached has been archived with permission from the editor of the Medical Journal of Australia. An external link to the publisher’s copy is included.Yoon-Sim Yap, Adrian Cummins, Peter Blumbergs, Jennifer Hardingham, Sunil Dabadghao and John Norma
Investigation of inflammatory and oxidative stress mechanisms in the disruption of white matter structure and function following chronic cerebral hypoperfusion
No full textVascular cognitive impairment (VCI) describes a heterogeneous condition caused
by cerebrovascular disease and disturbances in cerebral blood flow delivery. It is the
second leading form of dementia and vascular factors such as hypertension, diabetes
and obesity are associated with an increased risk of developing VCI. White matter
alterations are a prominent pathological feature observed in patients with VCI thought
to underlie cognitive impairment. Neuroimaging studies show a positive correlation
between the burden of white matter alterations and progressive cognitive impairment.
Similarly associated both with white matter alterations and cognitive impairment is
chronic cerebral hypoperfusion, sustained subtle reductions in cerebral blood flow.
Cerebral hypoperfusion is observed before the onset of cognitive decline in humans
and reducing cerebral blood flow in animal models replicates important aspects of
VCI, suggesting hypoperfusion is an early driver of white matter disruption and VCI.
Human neuropathology and preclinical animal models of chronic cerebral
hypoperfusion studies have repeatedly identified increased inflammation and
oxidative stress. This led to the hypothesis for this thesis; that inflammation and
oxidative stress are key drivers of structural and functional white matter disruption
when cerebral blood flow is reduced.
The studies reported in this thesis were developed to investigate mechanisms
involving inflammation and oxidative stress that can inform future treatments aimed
at preventing the disruption of white matter and cognitive impairment in VCI. One such
mechanism is the Nrf2 (Nuclear factor erythroid 2-related factor 2) signalling pathway.
Nrf2 is a transcription factor that acts to detect and resolve inflammation and oxidative
stress via induction of over 200 antioxidant and anti-inflammatory genes. Studies
have shown that modulation of Nrf2 alters levels of inflammation and oxidative stress
which impact on disease progression in models of Alzheimer’s disease, Parkinson’s
disease and multiple sclerosis. To date, no one has investigated the direct role of Nrf2
in cerebral hypoperfusion-induced white matter disruption. While Nrf2 represents a
promising network approach, another targeted mechanism of interest is microglial
proliferation. Many neurodegenerative diseases including human VCI demonstrate
increases in microglia, a sign of chronic neuroinflammation thought to be detrimental
to cells, tissues and synapses. Work by our group has found an association between
increasing numbers of microglia and the progressive disruption of white matter
structure and function when cerebral blood flow is reduced in a mouse model,
however, whether this is cause or consequence has yet to be determined. The first study of this thesis aimed to test the hypothesis that deficiency of Nrf2
exacerbates white matter pathology and cognitive decline when cerebral blood flow
is reduced. Using wild type and Nrf2 knockout mice the study investigated cortical
perfusion, white matter disruption and gliosis, cognitive impairment and white matter
gene changes following sham or surgically-induced cerebral hypoperfusion (bilateral
carotid artery stenosis). There were no differences in the severity of blood flow
reductions between genotypes initially, however, wild type mice displayed improved
recovery compared to Nrf2 deficient mice. Hypoperfusion induced white matter
disruption and microgliosis in the corpus callosum and the optic tract in both
genotypes, exacerbated by the absence of Nrf2. Further, hypoperfusion induced white
matter astrogliosis and upregulated pro-inflammatory gene signalling in the optic tract
and induced an impairment in spatial working memory. However, these measures
were not affected by Nrf2 deficiency. The results demonstrate that the absence of
Nrf2 exacerbates white matter pathology and microgliosis following cerebral
hypoperfusion but does not impact on functional outcome.
The second study aimed to test the hypothesis that enhancing astrocytic Nrf2-
signalling preserves white matter structure and cognitive decline when cerebral blood
flow is reduced. Astrocytes have larger antioxidant capacity than other cell types in
the brain and overexpressing Nrf2 in astrocytes is associated with reduced white
matter damage in a model of multiple sclerosis, as well as improved outcome in
models of Parkinson’s and Huntington’s disease. Similar to the first study, wild type
mice and mice overexpressing Nrf2 in astrocytes (GFAP-Nrf2) were subjected to
bilateral carotid artery stenosis and cortical perfusion, white matter disruption and
gliosis, cognitive impairment and white matter gene changes were assessed. There
were no differences in the severity of blood flow reductions between genotypes. Akin
to the first study, hypoperfusion induced white matter disruption, micro- and
astrogliosis and pro-inflammatory gene signalling in the optic tract. The majority of
these alterations were ameliorated in GFAP-Nrf2 mice. In addition, the impairment in
spatial working memory induced by cerebral hypoperfusion was modestly improved
in GFAP-Nrf2 mice compared to wild type controls. These findings support the
hypothesis that astrocytic Nrf2 preserves white matter structure and function following
cerebral hypoperfusion.
The first two studies identified structural and functional consequences of altered
inflammation mediated via alterations in Nrf2 signalling. To thoroughly investigate the
Nrf2 signalling pathway following cerebral hypoperfusion the next step would ideally have been to study microglial Nrf2, however due to the lack of a suitable animal
model, the third and final study instead aimed to test the hypothesis that microglial
colony-stimulating factor 1 receptor (CSF1R) signalling is a driver of white matter
disruption and cognitive decline when cerebral blood flow is reduced. Wild type mice
treated with a pharmacological inhibitor of CSF1R (GW2580) or vehicle control, as an
oral gavage or in diet, were studied by a similar experimental protocol as the first two
studies. There were no differences in the severity of cerebral hypoperfusion between
GW2580- or vehicle-treated animals either at one or six weeks following bilateral
carotid artery stenosis. One week of GW2580 treatment was shown to modulate
microglial proliferation and pro-inflammatory signalling in white matter. Remarkably,
treatment with GW2580 for six weeks completely rescued impairments in spatial
learning, protected against white matter disruption and prevented increased both
white matter micro- and astrogliosis compared to wild type controls. These results
suggest that CSF1R signalling in microglia is an important driver of the
pathophysiological mechanisms that lead to white matter disruption and cognitive
impairment when cerebral blood flow is reduced, and importantly, that targeted
inhibition of this improves functional outcome.
In conclusion, the work described in this thesis provides evidence of the
contribution of inflammation and oxidative stress to the disruption and functional
impairment of cerebral white matter. The results indicate that these mechanisms are
amenable to alteration, and that direct microglial inflammatory mechanisms play an
important role in the pathogenesis of white matter disruption and cognitive decline.
The results demonstrate that targeted inhibition of CSF1R signalling in microglia and
increased astrocytic Nrf2 expression leads to improved structural and functional
outcome and as such represent a basis for potential treatment which warrants further
investigation
Murder on the mountain: author talk with Peter J. Wosh
No full textAuthor talk by Peter J. Wosh on May 5th, 2022, on his book, "Murder on the Mountain: crime, passion, and punishment in gilded age New Jersey.
Mr. Melvin J. Collier, RWWL AUC, June 2011
No full textThis video is a conversation with Mr. Melvin J. Collier. Mr. Collier talks about his book, "From Mississippi to Africa: A Journey of Discovery". Daniel Le, AUC Woodruff Library, is the interviewer
TCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive manner
No full textAntagonists that are sufficiently selective to preferentially block GluN2A-containing N-methyl-d-aspartate receptors (NMDARs) over GluN2B-containing NMDARs are few in number. In this study we describe a pharmacological characterization of 3-chloro-4-fluoro-N-[4-[[2-(phenylcarbonyl)hydrazino]carbonyl]benzyl]benzenesulphonamide (TCN 201), a sulphonamide derivative, that was recently identified from a high-throughput screen as a potential GluN2A-selective antagonist. Using two-electrode voltage-clamp (TEVC) recordings of NMDAR currents from Xenopus laevis oocytes expressing either GluN1/GluN2A or GluN1/GluN2B NMDARs we demonstrate the selective antagonism by TCN 201 of GluN2A-containing NMDARs. The degree of inhibition produced by TCN 201 is dependent on the concentration of the GluN1-site co-agonist, glycine (or d-serine), and is independent of the glutamate concentration. This GluN1 agonist-dependency is similar to that observed for a related GluN2A-selective antagonist, N-(cyclohexylmethyl)-2-[{5-[(phenylmethyl)amino]-1,3,4-thiadiazol-2-yl}thio]acetamide (TCN 213). Schild analysis of TCN 201 antagonism indicates that it acts in a non-competitive manner but its equilibrium constant at GluN1/GluN2A NMDARs indicates TCN 201 is around 30-times more potent than TCN 213. In cortical neurones TCN 201 shows only modest antagonism of NMDAR-mediated currents recorded from young (DIV 9-10) neurones where GluN2B expression predominates. In older cultures (DIV 15-18) or in cultures where GluN2A subunits have been over-expressed TCN 201 gives a strong block that is negatively correlated with the degree of block produced by the GluN2B-selective antagonist, ifenprodil. Nevertheless, while TCN 201 is a potent antagonist it must be borne in mind that its ability to block GluN2A-containing NMDARs is dependent on the GluN1-agonist concentration and is limited by its low solubility
A Tripartite Post-Recession Rebalancing
No full textIn this latest Advance & Rutgers Report, entitled “A Tripartite Post-Recession Rebalancing,” Dean James W. Hughes and Professor Joseph J. Seneca deliver an incisive assessment of the current market conditions and obstacles in the path of our economic recovery. They offer a statistical cautionary tale that the private and public sector need to hear and acknowledge in order for the economy to make continued progress.This report was published as Issue Paper Number 7, November 2011, in Advance & Rutgers Report
Evidence for the decay B0→J/ψω and measurement of the relative branching fractions of meson decays to J/ψη and J/ψη′
No full textFirst evidence of the B 0 → J / ψ ω decay is found and the B s 0 → J / ψ η and B s 0 → J / ψ η ′ decays are studied using a dataset corresponding to an integrated luminosity of 1.0 fb -1 collected by the LHCb experiment in proton-proton collisions at a centre-of-mass energy of sqrt(s) = 7 TeV. The branching fractions of these decays are measured relative to that of the B 0 → J / ψ ρ 0 decay:frac(B (B 0 → J / ψ ω), B (B 0 → J / ψ ρ 0)) = 0.89 ± 0.19 (stat) - 0.13 + 0.07 (syst),frac(B (B s 0 → J / ψ η), B (B 0 → J / ψ ρ 0)) = 14.0 ± 1.2 (stat) - 1.5 + 1.1 (syst) - 1.0 + 1.1 (frac(f d, f s)),frac(B (B s 0 → J / ψ η ′), B (B 0 → J / ψ ρ 0)) = 12.7 ± 1.1 (stat) - 1.3 + 0.5 (syst) - 0.9 + 1.0 (frac(f d, f s)), where the last uncertainty is due to the knowledge of f d / f s, the ratio of b-quark hadronization factors that accounts for the different production rate of B 0 and B s 0 mesons. The ratio of the branching fractions of B s 0 → J / ψ η ′ and B s 0 → J / ψ η decays is measured to befrac(B (B s 0 → J / ψ η ′), B (B s 0 → J / ψ η)) = 0.90 ± 0.09 (stat) - 0.02 + 0.06 (syst)
The vanishing author in computer-generated works: a critical analysis of recent Australian case law
No full textAbstract
The use of software is ubiquitous in the creation of many copyright works, yet the requirement in copyright law that every work have a human author who engages in independent intellectual effort means that its use may prevent copyright subsistence. Several recent Australian cases have refocused attention on authorship as an essential criterion of copyright subsistence, and these cases suggest that much computer-produced output may be authorless and thus lack copyright protection. This article, the first in a two-part series, analyses how each case deals with the question of authorship of computer-produced works and why the use of software diminishes copyright protection for a significant number of computer-generated works. The article critiques the application of conventional notions of human authorship developed in the pre-computer age to modern productions and suggests alternative approaches to authorship that satisfy both the major objectives of copyright policy and the need to adapt to the computer age. The article argues that, without a broader judicial approach to authorship of computer-generated works, Parliament must remedy the lacuna in protection for these ‘authorless’ works. Possible solutions for reform are suggested. In a forthcoming article, the author comprehensively examines those reform proposals
- …
